| Metric | FY2024 | FY2023 |
|---|---|---|
| Net loss | -$12.9M+69.7% | -$42.4M |
| Depreciation of equipment | $11K-91.1% | $124K |
| Gain on sale of equipment | -$59K | $0 |
| Impairment of intangible assets | $0-100.0% | $28.7M |
| Impairment of goodwill | $0-100.0% | $4.8M |
| Impairment of assets held for sale | $0-100.0% | $400K |
| Stock-based compensation | $913K-49.6% | $1.8M |
| Change in fair value of warrant liabilities | $2.7M+27380.0% | -$10K |
| Deferred income tax benefit | -$1.8M+80.8% | -$9.5M |
| Unrealized foreign exchange (gain) loss | $0-100.0% | $5K |
| Loss on disposal | $39K+0.0% | $39K |
| Receivables | $80K+126.5% | -$302K |
| Prepaid expenses | $315K+337.5% | $72K |
| Trade and other payables | -$1.7M-501.9% | $411K |
| Operating lease right of use asset | -$23K | $0 |
| Net cash used in operating activities | -$12.3M+22.5% | -$15.9M |
| Purchase of equipment | -$22K-29.4% | -$17K |
| Proceeds from sale of equipment | $111K | $0 |
| Purchase of short-term investments | -$6.6M-30.7% | -$5.0M |
| Maturity of short-term investments | $6.6M-63.9% | $18.2M |
| Net cash provided by investing activities | $104K-99.2% | $13.2M |
| Net proceeds from issuance of common shares and warrants from private placement | $7.3M | $0 |
| Proceeds from issuance of common shares from exercise of stock options | $21K | $0 |
| Net proceeds from shares issued under the at-the-market (ATM) program | $0-100.0% | $304K |
| Net cash provided by financing activities | $7.4M+2320.7% | $304K |
| Effect of exchange rate fluctuations on cash and cash equivalents | $0+100.0% | -$8K |
| Net decrease in cash and cash equivalents | -$4.9M-97.6% | -$2.5M |
| Cash and cash equivalents, beginning of year | $27.9M-8.1% | $30.3M |
| Cash and cash equivalents, end of year | $23.0M-17.5% | $27.9M |
| Cash | $3.3M-81.6% | $17.8M |
| Cash equivalents | $19.7M+95.8% | $10.1M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.